Previous 10 | Next 10 |
home / stock / ctabf / ctabf news
TORONTO, Ontario , Nov. 20, 2019 /PRNewswire/ -- Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, today announced the signing o...
Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States Canntab Achieves Key Milestone: Canntab Enters Into Supply &a...
Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities Canada NewsWire TORONTO, Oct. 8, 2019 TORONTO , Oct. 8, 2019 /CNW/ - Canntab Therapeutics Limited ( CSE:PILL.CN ) ( OTCQX:CTABF ) ( FRA:TBF...
Vancouver, British Columbia--(Newsfile Corp. - August 16, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, has received an initial assessment from the Geneva-based Internati...
Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation Canada NewsWire TORONTO, Aug. 15, 2019 TORONTO , Aug. 15, 2019 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN ) (OTCQX: CTABF ) (FRA: TBF1.F ) (the " Compa...
Vancouver, British Columbia--(Newsfile Corp. - August 1, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has updated investors about significant developments. Canntab, with headquarters ...
Commercial batch manufacturing of oil-filled gel capsules to begin in Cobourg , leading to a Health Canada request for authorization to begin full scale production and sale. Construction nears completion in Markham , and Canntab intends to request a Health Canada inspection in early fal...
ATLANTA, GA / ACCESSWIRE / June 24, 2019 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its June/July 2019 Issue of the U.S. and Canadian CannaInvestor ...
TORONTO, ON / ACCESSWIRE / June 24, 2019 / Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQX: CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, is pleased to announce that it is the featured company...
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE: TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has signed a term sheet with Heritage Cannabis Holdings. Under the Term Sheet, Ca...
News, Short Squeeze, Breakout and More Instantly...
Canntab Therapeutics Ltd Company Name:
CTABF Stock Symbol:
OTCMKTS Market:
Canntab Therapeutics Ltd Website:
Toronto, Ontario--(Newsfile Corp. - September 18, 2023) - Canntab Therapeutics Limited (CSE: PILL) (OTC Pink: CTABF) (FSE: TBF1) (the " Corporation ") announces that the Ontario Securities Commission (the " OSC ") has rejected the Corporation's application for a management cease trade order (the ...
TORONTO, ON / ACCESSWIRE / November 22, 2022 / Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF)(FRA:TBF1) (the " Company " or " Canntab ") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is providing an update on several matters impac...
CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET Canada NewsWire TORONTO , Aug. 22, 2022 /CNW/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the " Company " or " Canntab ") a leading innovator in cannabi...